Jasper Therapeutics announced the appointment of Vishal Kapoor, Partner of Avego Management, to Jasper’s Board of Directors. Kapoor has been a Partner of Avego Management, LLC, an affiliate of Velan Capital, since January 2021.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on JSPR:
- Jasper Therapeutics Appoints Industry Veteran Vishal Kapoor to its Board of Directors
- Jasper Therapeutics Announces Positive Follow-up Clinical Data from Investigator-Sponsored Study of Briquilimab Conditioning in Fanconi Anemia Patients at the 2023 Transplantation & Cellular Therapy Meetings of the ASTCT and CIBMTR
- Jasper Therapeutics Presents Data Supporting Ongoing Development of Briquilimab, its c-Kit Targeting Antibody, at the 2023 Transplantation & Cellular Therapy Meetings of the ASTCT and CIBMTR
- Jasper Therapeutics announces follow-up data from briquilimab study for SCD
- Jasper Therapeutics Announces Positive Follow-up Clinical Data from Investigator-Sponsored Study of Briquilimab Conditioning in Sickle Cell Disease Patients